Objectives: Nitric oxide (NO) is produced within the respiratory tract and can be detected in exhaled bronchial and nasal air with correlation to specific diseases (elevated in asthma/bronchiectasis, decreased in ciliar dysfunction). NO in paranasal sinuses is considered as location-specific first line defense mechanism. In CF, NO levels are reported divergently as low or normal. Aim of this study was to investigate correlation of upper and lower airway NO levels to pathogen colonization, clinics and blood inflammatory parameters. Methods: From 57 CF patients nasal and bronchial NO was correlated to pathogen colonization of the upper and lower airways and clinical parameters. Airway microbiology was preferably assessed by nasal lavage using 10 ml NaCl 0.9% per nasal side and sputum sampling. Results: Nasal and bronchial NO levels were significantly correlated to each other, but not to specific pathogen colonization. In patients receiving azithromycin, a tendency to reduced NO could be found. Interestingly, a significant inverse correlation between C-reactive protein and leucocytes and nasal NO was found. In contrast, bronchial NO levels showed no correlation to clinical parameters, lung function, body mass index, or inflammatory parameters. Conclusion: Assessment of nasal and bronchial NO levels can contribute to understand pathogen defense mechanisms in both airway levels in CF and other diseases, and for its non-invasiveness, it allows repeated controls. Supposing NO (in particular in the paranasal sinus) is part of first line defense mechanism against pathogens, further research may help preventing early colonization and improve therapy options and outcome in CF. Factors identified as affecting the success of treatment were BMI before treatment; age on admission; genotype; chronic oral antibiotics; courses of IV antibiotics completed at home; and semi-elective, compared to symptomatic, admissions. When multiple samples were taken on the same day, 70.8% (n = 17) were found to be nonconcordant. The negative predictive value of cough swabs was 30.8%. Conclusions: This is the first analysis of the rationalised protocol at the unit. The rationalised protocol appears to have had no effect upon clinical outcome but has reduced the cost of testing. Previous findings of poor predictability of cough swab samples are replicated and some factors predictive of treatment failure are identified.
